Brief: Regeneus Says FY Net Loss For Year Attributable A$4.3 Mln
30/08/2022 06:50
Aug 30 (Reuters) - Regeneus Ltd RGS.AX :
* FY NET LOSS FOR YEAR ATTRIBUTABLE A$4.3 MILLION VERSUS
LOSS
A$7.1 MILLION
Further company coverage: RGS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cambium Bio
See all newsAustralia's Cambium Bio hits near three-month high on share placement at premium
Brief: Cambium Bio Appoints Olga Smejkalova As Company Secretary
Australia's Cambium Bio gains after premium share placement
Brief: Cambium Bio Raises A$1 MLN At A$0.48 Per Share
Brief: Cambium Bio Receives A$2.4 Million Investment From Zheng Yang Biomedical Technology